Macomics

Macomics is a macrophage drug discovery company that develops novel treatments for diseases where current therapeutics are limited or ineffective. The company focuses on targeting macrophage activity to change the course of disease through its proprietary science and pipeline. Its research and development efforts are primarily directed toward the field of immuno-oncology and therapeutic macrophage biology.